These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 2921809)
1. [A clinicopathological study of advanced ovarian cancers without an enlargement of the ovaries]. Kawagoe K; Kawana T; Mizuno M Gan No Rinsho; 1989 Jan; 35(1):46-50. PubMed ID: 2921809 [TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
3. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II. Young RH Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777 [TBL] [Abstract][Full Text] [Related]
5. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases. Veras E; Deavers MT; Silva EG; Malpica A Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma. Seidman JD; Wang BG Gynecol Oncol; 2007 Jul; 106(1):201-6. PubMed ID: 17477958 [TBL] [Abstract][Full Text] [Related]
7. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study. Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688 [TBL] [Abstract][Full Text] [Related]
8. Lung carcinoma metastatic to the ovary: a clinicopathologic study of 32 cases emphasizing their morphologic spectrum and problems in differential diagnosis. Irving JA; Young RH Am J Surg Pathol; 2005 Aug; 29(8):997-1006. PubMed ID: 16006793 [TBL] [Abstract][Full Text] [Related]
9. [Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer]. Demeter A; Szirmai K; Oláh J; Papp Z; Jeney A Orv Hetil; 2004 Aug; 145(31):1617-24. PubMed ID: 15384859 [TBL] [Abstract][Full Text] [Related]
10. Borderline tumors of the ovary. Barakat RR Obstet Gynecol Clin North Am; 1994 Mar; 21(1):93-105. PubMed ID: 8015769 [TBL] [Abstract][Full Text] [Related]
11. The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Chi DS; Venkatraman ES; Masson V; Hoskins WJ Gynecol Oncol; 2000 May; 77(2):227-31. PubMed ID: 10785469 [TBL] [Abstract][Full Text] [Related]
12. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Gilks CB; Ionescu DN; Kalloger SE; Köbel M; Irving J; Clarke B; Santos J; Le N; Moravan V; Swenerton K; Hum Pathol; 2008 Aug; 39(8):1239-51. PubMed ID: 18602670 [TBL] [Abstract][Full Text] [Related]
13. [Assessment of prognostic factors in common ovarian tumors of varying malignancy]. Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877 [TBL] [Abstract][Full Text] [Related]
14. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838 [TBL] [Abstract][Full Text] [Related]
16. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results. Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613 [TBL] [Abstract][Full Text] [Related]
17. Clinical factors and biomarkers in ovarian tumors development. Vrabie CD; Petrescu A; Waller M; Dina I Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637 [TBL] [Abstract][Full Text] [Related]
18. Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability. Okamura H; Katabuchi H Ital J Anat Embryol; 2001; 106(2 Suppl 2):263-76. PubMed ID: 11732586 [TBL] [Abstract][Full Text] [Related]
19. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma. Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148 [TBL] [Abstract][Full Text] [Related]
20. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases. Ordi J; Schammel DP; Rasekh L; Tavassoli FA Mod Pathol; 1999 Oct; 12(10):933-40. PubMed ID: 10530556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]